drugset / Trial / NCT00975663

Bayesian Dose Adjustment of Immunosuppressants After Lung Transplantation

NCT00975663

Phase 4 Terminated 180 enrolled University Hospital, Limoges
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate in lung or heart-lung transplant patients on tacrolimus and mycophenolate the impact of optimized mofetil (MMF) therapeutic drug monitoring and dose adjustment of both drugs on the incidence of treatment failure over the first three years post-transplantation.

Timeline

Start
2009-09
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mycophenolate Mofetil Small molecule
Comparator Tacrolimus Small molecule Oral

Indications

No indication recorded.